|
IPO Open | Jan 16, 2023 |
IPO Close | Jan 19, 2023 |
IPO Price | ₹72 |
Face Value | ₹10 |
IPO Size | ₹13.05 Cr |
Listing At | NSE SME |
Lot Size | 1600 |
Jan 13, 2023 5:31:00 PM
The Initial Public Offer (IPO) of Aristo Bio - Tech And Lifescience Limited will take place in the next week, on January 16, 2023. By issuing 18,12,800 shares at a price of ?72 per share ...
Publish by : MintJan 16, 2023 11:00:00 AM
The Initial Public Offering (IPO) of Aristo Bio-Tech And Lifescience Limited opens today, 16 January. The firm aims to raise Rs 13.05 crore with the issue. The company is issuing 18,12,800 shares at a ...
Publish by : FirstpostJan 17, 2023 3:20:00 PM
Aristo Bio - Tech And Lifescience Limited's initial public offering (IPO) opened for public subscription on Monday, January 16, 2023, and will conclude on Thursday, January 19, 2023, and will ...
Publish by : MintJan 16, 2023 10:25:00 AM
The initial public offering (IPO) of Gujarat-based Aristo Bio-tech and Lifescience Ltd. opens for subscription today, January 16, for retail investors. The SME (small and medium enterprise ...
Publish by : MSNJan 13, 2023 8:14:00 PM
New Delhi [India], January 13 (ANI/PNN): Aristo Bio-tech and Lifescience Limited ... is coming up with its IPO for 18,12,800 shares to raise Rs 1305.22 lakhs. The face value per equity share is Rs 10 ...
Publish by : ThePrintJan 16, 2023 6:14:00 AM
Aristo Bio-Tech And Lifescience is aiming to raise Rs 1,3.05 crore with its IPO. The IPO’s lead manager is Beeline Capital Advisors Private Limited, a renowned merchant banking firm in Gujarat ...
Publish by : FirstpostJan 13, 2023 7:46:00 PM
New Delhi [India], January 13 (ANI/PNN): Aristo Bio-tech and Lifescience Limited ... is coming up with its IPO for 18,12,800 shares to raise Rs 1305.22 lakhs. The face value per equity share is Rs 10 ...
Publish by : Net India 123The allotment status of Aristo Bio-Tech and Lifescience Limited IPO is now available online. The public issue of Aristo Bio-Tech and Lifescience IPO was open on Jan 16, 2023 and closed for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME
.
The IPO Shares of Aristo Bio-Tech and Lifescience Limited IPO are proposed to list on Monday, January 30, 2023 at NSE SME. The public issue of Aristo Bio-Tech and Lifescience IPO was opened on Jan 16, 2023 and closed for subscription on Jan 19, 2023. Aristo Bio-Tech and Lifescience IPO Listing Date and Information:
Listing Date | Monday, January 30, 2023 |
BSE Script Code | |
NSE Symbol | ARISTO |
Listing In | |
ISIN | |
Issue Price | ₹72 Per Equity Share |
Face Value | ₹10 Per Equity Share |
SME : Aristo Bio-Tech and Lifescience Limited is entering in the capital market with an IPO of 1,812,800 Equity Shares of Rs 10 aggregating up to Rs 13.05 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
The issue opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME.
SME: The issue of Aristo Bio-Tech and Lifescience Limited opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Aristo Bio-Tech and Lifescience IPO is proposed to open on Jan 16, 2023. The IPO application ends on Jan 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from Jan 16, 2023 to Jan 19, 2023. The Aristo Bio-Tech and Lifescience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Aristo Bio-Tech and Lifescience IPO will open for subscription on Jan 16, 2023. The public issue will close on Jan 19, 2023.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|